Market Overview:
The global protein kinase C theta market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer, rising awareness about cancer treatments, and growing investments by key players in this market. Based on type, the global protein kinase C theta market is segmented into AS-2521780, CC-0739623, CGX-0471, CGX-1079 and others. Based on application, the global protein kinase C theta market is segmented into Ewing sarcoma (ES), insulin resistance (IR), kidney cancer (KC), obesity and others. Geographically, North America dominates this market followed by Europe and Asia Pacific.
Product Definition:
Protein Kinase C Theta is a protein kinase that is involved in the regulation of cell proliferation, differentiation and survival. It has been implicated in a number of diseases, including cancer.
AS-2521780:
AS-2521780 is a selective inhibitor of protein kinase C theta. Protein Kinase C (PKC) is one of the most important enzymes involved in cellular signaling and control. The enzyme specifically regulates certain cell functions such as proliferation, apoptosis, differentiation, and motility. PKC plays an important role in various diseases including cancer and diabetes by regulating several physiological processes such as energy metabolism, neurodegeneration & inflammation through different intracellular pathways.
CC-0739623:
CC-0739623 is a selective inhibitor of protein kinase C theta. Protein Kinase C Theta (PKC THE) is an enzyme that phosphorylates serine and threonine residues in various proteins, including importins, cyclooxygenases, platelet-derived growth factors and vascular endothelial growth factors.
Application Insights:
The application segment of the global protein kinase C theta market is categorized into Ewing sarcoma, insulin resistance, kidney cancer, obesity and others. Among these applications, Ewing sarcoma held the largest share in 2017 owing to its high incidence rate and prevalence in various regions including North America and Europe.
Insulin resistance is expected to be one of the fastest-growing segments during forecast period due to its rising incidences such as type 2 diabetes mellitus which causes significant disease burden globally. The increasing number of patients suffering from insulin resistant conditions coupled with growing demand for innovative drugs that can cure this condition will boost product demand over the forecast period.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance during the forecast period owing to high R&D investments and presence of key players. Moreover, increasing prevalence of cancer and other diseases coupled with rising government funding for protein kinase C-theta inhibitors are some factors that can be attributed to regional market growth. For instance, in March 2018, Pfizer Inc., a U.S.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is expected to drive the demand for Protein Kinase C Theta inhibitors over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth as this population is more susceptible to chronic diseases.
- Rising R&D expenditure by pharmaceutical companies for novel therapeutics is projected to propel the Protein Kinase C Theta market growth during the forecast period.
- increasing number of clinical trials for development of novel therapies will fuel demand for Protein Kinase C Theta inhibitors in coming years
Scope Of The Report
Report Attributes
Report Details
Report Title
Protein Kinase C Theta Market Research Report
By Type
AS-2521780, CC-0739623, CGX-0471, CGX-1079, Others
By Application
Ewing Sarcoma, Insulin Resistance, Kindney Cancer, Obesity, Others
By Companies
AbbVie Inc, Astellas Pharma Inc, Celgene Corp, CompleGen Inc, Takeda Pharmaceutical Co Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Protein Kinase C Theta Market Report Segments:
The global Protein Kinase C Theta market is segmented on the basis of:
Types
AS-2521780, CC-0739623, CGX-0471, CGX-1079, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ewing Sarcoma, Insulin Resistance, Kindney Cancer, Obesity, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie Inc
- Astellas Pharma Inc
- Celgene Corp
- CompleGen Inc
- Takeda Pharmaceutical Co Ltd
Highlights of The Protein Kinase C Theta Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- AS-2521780
- CC-0739623
- CGX-0471
- CGX-1079
- Others
- By Application:
- Ewing Sarcoma
- Insulin Resistance
- Kindney Cancer
- Obesity
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Protein Kinase C Theta Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Protein Kinase C Theta is a protein that helps control the activity of other proteins. It helps to regulate cell signaling and can help to control the growth and division of cells.
Some of the major players in the protein kinase c theta market are AbbVie Inc, Astellas Pharma Inc, Celgene Corp, CompleGen Inc, Takeda Pharmaceutical Co Ltd.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Protein Kinase C Theta Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Protein Kinase C Theta Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Protein Kinase C Theta Market - Supply Chain
4.5. Global Protein Kinase C Theta Market Forecast
4.5.1. Protein Kinase C Theta Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Protein Kinase C Theta Market Size (000 Units) and Y-o-Y Growth
4.5.3. Protein Kinase C Theta Market Absolute $ Opportunity
5. Global Protein Kinase C Theta Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Protein Kinase C Theta Market Size and Volume Forecast by Type
5.3.1. AS-2521780
5.3.2. CC-0739623
5.3.3. CGX-0471
5.3.4. CGX-1079
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Protein Kinase C Theta Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Protein Kinase C Theta Market Size and Volume Forecast by Application
6.3.1. Ewing Sarcoma
6.3.2. Insulin Resistance
6.3.3. Kindney Cancer
6.3.4. Obesity
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Protein Kinase C Theta Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Protein Kinase C Theta Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Protein Kinase C Theta Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Protein Kinase C Theta Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Protein Kinase C Theta Demand Share Forecast, 2019-2026
9. North America Protein Kinase C Theta Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Protein Kinase C Theta Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Protein Kinase C Theta Market Size and Volume Forecast by Application
9.4.1. Ewing Sarcoma
9.4.2. Insulin Resistance
9.4.3. Kindney Cancer
9.4.4. Obesity
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Protein Kinase C Theta Market Size and Volume Forecast by Type
9.7.1. AS-2521780
9.7.2. CC-0739623
9.7.3. CGX-0471
9.7.4. CGX-1079
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Protein Kinase C Theta Demand Share Forecast, 2019-2026
10. Latin America Protein Kinase C Theta Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Protein Kinase C Theta Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Protein Kinase C Theta Market Size and Volume Forecast by Application
10.4.1. Ewing Sarcoma
10.4.2. Insulin Resistance
10.4.3. Kindney Cancer
10.4.4. Obesity
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Protein Kinase C Theta Market Size and Volume Forecast by Type
10.7.1. AS-2521780
10.7.2. CC-0739623
10.7.3. CGX-0471
10.7.4. CGX-1079
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Protein Kinase C Theta Demand Share Forecast, 2019-2026
11. Europe Protein Kinase C Theta Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Protein Kinase C Theta Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Protein Kinase C Theta Market Size and Volume Forecast by Application
11.4.1. Ewing Sarcoma
11.4.2. Insulin Resistance
11.4.3. Kindney Cancer
11.4.4. Obesity
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Protein Kinase C Theta Market Size and Volume Forecast by Type
11.7.1. AS-2521780
11.7.2. CC-0739623
11.7.3. CGX-0471
11.7.4. CGX-1079
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Protein Kinase C Theta Demand Share, 2019-2026
12. Asia Pacific Protein Kinase C Theta Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Protein Kinase C Theta Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Protein Kinase C Theta Market Size and Volume Forecast by Application
12.4.1. Ewing Sarcoma
12.4.2. Insulin Resistance
12.4.3. Kindney Cancer
12.4.4. Obesity
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Protein Kinase C Theta Market Size and Volume Forecast by Type
12.7.1. AS-2521780
12.7.2. CC-0739623
12.7.3. CGX-0471
12.7.4. CGX-1079
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Protein Kinase C Theta Demand Share, 2019-2026
13. Middle East & Africa Protein Kinase C Theta Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Protein Kinase C Theta Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Protein Kinase C Theta Market Size and Volume Forecast by Application
13.4.1. Ewing Sarcoma
13.4.2. Insulin Resistance
13.4.3. Kindney Cancer
13.4.4. Obesity
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Protein Kinase C Theta Market Size and Volume Forecast by Type
13.7.1. AS-2521780
13.7.2. CC-0739623
13.7.3. CGX-0471
13.7.4. CGX-1079
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Protein Kinase C Theta Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Protein Kinase C Theta Market: Market Share Analysis
14.2. Protein Kinase C Theta Distributors and Customers
14.3. Protein Kinase C Theta Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AbbVie Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Astellas Pharma Inc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Celgene Corp
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CompleGen Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Takeda Pharmaceutical Co Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
